May 27, 2021
Today, Oisín Biotechnologies, a well-known developer of senolytics, drugs that destroy harmful senescent cells, has announced that it has more than doubled its total funding through an oversubscribed round. This has taken its total funding from $4.5 million to $9.5 million. Cellular SenescenceAs your body ages, more of your cells become senescent. Senescent cells do...